Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Data Center & Digital Infra ETF (DTCR) vs Novo Nordisk A/S (NVO) Price & Performance

Global X Data Center & Digital Infra ETFTrade
Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

Global X Data Center & Digital Infra ETF vs Novo Nordisk A/S — how do they compare? Global X Data Center & Digital Infra ETF trades at $27.74 (market cap $2.04B), while Novo Nordisk A/S trades at $38.45 (market cap $165.31B). The key difference: Novo Nordisk A/S is far larger — about 81× Global X Data Center & Digital Infra ETF's market cap, and Novo Nordisk A/S pays a 4.71% dividend while Global X Data Center & Digital Infra ETF pays none. Which is the better fit depends on your goals.

DTCRNVO
Market Cap
$2.04B$165.31B
Volume
899,53211,432,838
Sector
Sector/ThematicHealth
52-Week High
$32.46$63.98
52-Week Low
$19.73$35.29
Typical Hold Time
15 Days—
Enterprise Value
—$179.56B
Dividend Yield
—4.71%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Data Center & Digital Infra ETF

No Aura AI signal available yet.

Novo Nordisk A/S

Novo Nordisk (NVO) trades at $38.41, up 0.38% with strong fundamentals including 35.35% net margin and consistent earnings beats. The stock shows bearish technical signals but maintains robust profitability with $102.43B net income. Recent news highlights pipeline developments including Wegovy pill data and FDA reviews, while competition with Eli Lilly intensifies in the obesity drug market.

NVO presents a compelling value opportunity with a 9.66 P/E ratio and 59% upside to the $44.67 consensus target. However, technical weakness and competitive pressures from Lilly's new drug candidates pose near-term risks. The company's strong cash flow generation and 59.82% ROE support long-term growth prospects despite regulatory uncertainties.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DTCR
100% Buy0% Sell
Avg holding period · 15 Days
NVO
96% Buy4% Sell

Top news

Latest headlines on both assets

About Global X Data Center & Digital Infra ETF

Global X Data Center & Digital Infrastructure ETF seeks exposure to companies involved in data centers and digital infrastructure. Its holdings span areas such as digital infrastructure, networking, and related real estate.

Read more on DTCR →

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO →